
Organovo Holdings, Inc.
CEO
Keith E. Murphy
IPO Date
2012-02-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 19,607 |
| $0.00 |
| 9 Aug 2024 | Milhous Alison Tjosvold | director | A-Award | Acquired | 19,607 | $0.00 |
| 9 Aug 2024 | Gobel David | director | A-Award | Acquired | 19,607 | $0.00 |
| 7 Aug 2024 | Murphy Keith | director, officer: EXECUTIVE CHAIRMAN | A-Award | Acquired | 574,923 | $0.54 |
| 7 Aug 2024 | Murphy Keith | director, officer: EXECUTIVE CHAIRMAN | A-Award | Acquired | 143,731 | $0.54 |
| 7 Aug 2024 | Murphy Keith | director, officer: EXECUTIVE CHAIRMAN | A-Award | Acquired | 19,607 | $0.00 |
| 17 Nov 2023 | STERN ADAM K | director | A-Award | Acquired | 19,607 | $0.00 |
| 17 Nov 2023 | Murphy Keith | director, officer: Executive Chairman | A-Award | Acquired | 19,607 | $0.00 |
| 17 Nov 2023 | Cohen Douglas Jay | director | A-Award | Acquired | 19,607 | $0.00 |